- Health & Pharmaceuticals›
- Physicians, Hospitals & Pharmacies›
Length of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
Length of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure
by John Elflein,
last edited
Jan 30, 2018
This statistic depicts the average number of days a patient will stay in the hospital for an hematopoietic stem cell (HSC) transplant in the United States as of 2014, by procedure type. According to the data, in 2014, a cord blood stem cell transplant required an average of 51.2 days in the hospital.
Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure
Loading statistic...
| Number of days | |
|---|---|
| Cord blood stem cell transplant | 51.2 |
| Allogeneic bone marrow transplant without purging | 37.5 |
| Allogeneic HSC transplant with purging | 33.5 |
| Allogeneic HSC transplant without purging | 30.6 |
| Autologous bone marrow transplant without purging | 19.6 |
| Autologous HSC transplant without purging | 18.5 |
| Number of days | |
|---|---|
| Cord blood stem cell transplant | 51.2 |
| Allogeneic bone marrow transplant without purging | 37.5 |
| Allogeneic HSC transplant with purging | 33.5 |
| Allogeneic HSC transplant without purging | 30.6 |
| Autologous bone marrow transplant without purging | 19.6 |
| Autologous HSC transplant without purging | 18.5 |
© Statista 2019
About this statistic
Sources: RAND Corporation; AHRQ (HCUP)
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by John Elflein,
last edited
Jan 30, 2018
This statistic depicts the average number of days a patient will stay in the hospital for an hematopoietic stem cell (HSC) transplant in the United States as of 2014, by procedure type. According to the data, in 2014, a cord blood stem cell transplant required an average of 51.2 days in the hospital.
- Sources
- RAND Corporation; AHRQ (HCUP)
- Show further sources information
- Show publisher information
- Release date
- September 2017
- Region
- United States
- Survey time period
- 2014
Free access to basic statistics
Source
- Sources
- RAND Corporation; AHRQ (HCUP)
- Show further sources information
- Show publisher information
- Release date
- September 2017
More information
- Region
- United States
- Survey time period
- 2014
Other statistics on the topic
+Pharmaceutical Products & Market
Global cell and gene therapy market forecast 2012-2020
+Pharmaceutical Products & Market
Global stem cell market size forecast 2025
+Pharmaceutical Products & Market
Regenerative medicine companies by world region 2019
+Health System
View of increasing government funding for stem cell research - U.S. adults 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Cell and gene therapy
- 72 page/s
- English
- pptx
- Detailed references
Everything On "Cell and gene therapy" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Cell and gene therapy"
- Market overview
The most important statistics
- Projected global market size for regenerative medicine from 2016 to 2025 (in billion euros)Global market size for regenerative medicine from 2016-2025
- Global cell and gene therapy market forecast between 2012 and 2020 (in billion U.S. dollars)Global cell and gene therapy market forecast 2012-2020
- Global cell culture market size from 2012 to 2022 (in million U.S. dollars)Global cell culture market size 2012-2022
- Distribution of advanced therapy medicinal products (ATMP) by classification worldwide as of 2016ATMP classification share worldwide 2016
- Distribution of regenerative medicine companies by world region as of 2019*Regenerative medicine companies by world region 2019
- Market capitalization of selected larger gene and cell therapy companies in the U.S. as of 2017 (in billion U.S. dollars)*Market cap of larger gene and cell therapy companies in U.S. as of 2017
- R&D/trials
The most important statistics
- Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phaseATMP trials classification share by disease and development phase globally 2016
- Distribution of advanced therapy medicinal product (ATMP) clinical trials by type of sponsor worldwide as of 2016ATMP clinical trials share globally by type of sponsor
- Distribution of non-commercial advanced therapy medicinal product (ATMP) trials by sponsor worldwide as of 2016ATMP clinical trials non-commercial sponsors distribution globally 2016
- Number of stem-cell and gene therapies in current development as of 2017, by developerNumber of biotech therapies in development as of 2017, by developer
- Percentage of stem-cell and gene therapies in current development as of 2017, by developerPercentage of biotech therapies in development as of 2017, by developer
- Stem cells
The most important statistics
- Global stem cell market size by world region between 2011 and 2016 (in billion U.S. dollars)*Global stem cell market size by world region 2011-2016
- Distribution of the stem cell technologies and applications market by world region in 2016Stem cell technologies and applications market share by world region 2016
- Global stem cell market size in 2016 and a forecast for 2025 (in billion U.S. dollars)*Global stem cell market size forecast 2025
- Number of hematopoietic stem cell (HSC) transplants in the United States from 2010 to 2015, by sourceNumber of HSC transplants in the US from 2010-2015, by source
- Total stem cell research funding by the National Institutes for Health (NIH) from FY 2013 to FY 2018 (in million U.S. dollars)Total stem cell research funding by the National Institutes for Health 2013-2018
- Cord blood
The most important statistics
- Aggregate annual demand of cord blood units (CBUs) in the U.S. from 2010 to 2016*Aggregate annual demand for cord blood units from 2010-2016
- Average annual social value of the U.S. cord blood bank system based on donor/patient matching from 2010 to 2016 (in million U.S. dollars) Annual social value of U.S. CBB system by scenario 2010-2016
- Percentage of cord blood units (CBUs) from the U.S. shipped to domestic and international destinations from 2010 to 2016Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016
- Share of U.S. cord blood units (CBUs) shipped by the U.S. by total nucleated cell count (TNC) from 2002 to 2016Percentage of shipped U.S. cord blood units by TNC count 2002-2016
- Share of U.S. cord blood units (CBUs) stored by total nucleated cell count (TNC) from 2002 to 2016Percentage of stored U.S. CBUs by TNC count 2002-2016
- CAR/CAR-T
The most important statistics
- Number of CAR cell therapy trials worldwide from 2007 to 2016*Number of CAR cell therapy trials worldwide 2007-2016
- Number of CAR cell therapy trials, comparing the U.S. and China from 2009 to 2016*Number of CAR cell therapy trials U.S. vs China 2009-2016
- Venture capital funding for select companies involved in CAR-T programs between 2011 and 2016 (in million U.S. dollars)*Venture capital funding for companies in CAR-T programs 2011-2016
- Selected IPOs of companies with a CAR-T focus between 2013 and 2015 (in million U.S. dollars)*IPO value of select CAR-T companies 2013-2015
- Miscellaneous
The most important statistics
- Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedureLength of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
- Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars)Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*Capital raised by regenerative medicine companies worldwide 2016-2018
- Price of select market-stage advanced therapy medicinal products (ATMPs) as of 2016 (in U.S. dollars)Select market-stage ATMPs price in the U.S. as of 2016
- Do you favor or oppose expanding federal funding for research using embryonic stem cells?View of increasing government funding for stem cell research - U.S. adults 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Hospital costs for an HSC transplant in the U.S. in 2014, by procedure
- Medicare charges and costs for an HSC transplant in 2014, by procedure
- Hospital charges for an HSC transplant in the U.S. in 2014, by procedure
- Number of HSC transplants in the US from 2010-2016, by condition and source
- Number of HSC transplants in the US from 2010-2016, by condition
- Number of HSC transplants in the US from 2010-2015
- Adults with outpatient hospital treatments in preceding 5 years 2017, by gender
- Level of satisfaction with hospital treatments among U.S. adults 2017, by ethnicity
- U.S. population with delayed or not received medical care due to cost 2000-2016
- Level of satisfaction with hospital treatments among U.S. adults 2017, by age
- Americans' moral stance towards using stem cells obtained from human embryos in 2018
- Level of satisfaction with hospital treatments among U.S. adults 2017, by gender
- Medical conditions U.S. health care workers have been treated for in hospitals 2017
- Latin America: stem cell assay market value 2018-2023
- Medical conditions U.S. adults have been treated for in hospitals 2017, by community
- Level of satisfaction with public hospital services in Hong Kong 2019
- Argentina: blood & hematopoietic organs pharmaceuticals revenue 2017-2018
- Alcoholic liver disease hospital admissions in England 2013/14, by type
- Italy: number of pancreatic islets and parathyroid tissue donations 2014-2017
- Number of hospitals in New Mexico 2017 by ownership
Studies
- Hospital footfall in the United Kingdom (UK)
- Wait Time for Treatment in Hospital Emergency Departments: 2009
- Hospital Statistics: Mental Health and Learning Disability 2015/16
- Hospital Statistics: Mental Health and Learning Disability 2014/15.
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- Hospital Admitted Patient Care and Adult Critical Care Activity 2017-18
- Queen Elizabeth National Spinal Injuries Unit for Scotland Annual Report 2017-2018
- HealthGrades 2012 America's Best Hospitals Report
- ED Success: Coordinating Emergent and Nonemergent Care
- Patient Experience Excellence: Transforming Culture Across the Continuum
- Strategic Cost Control: Beyond Traditional Tactics
- HealthGrades America´s 50 best Hospital Report (February 2011)
- Medical Tourism Association - Hospital Survey 2009
- The Eleventh Annual HealthGrades Hospital Quality in America Study
- HealthGrades 2013 America's Best Hospitals Report
Statistics on "Cell and gene therapy"
- Projected global market size for regenerative medicine from 2016 to 2025 (in billion euros)
- Global cell and gene therapy market forecast between 2012 and 2020 (in billion U.S. dollars)
- Global cell culture market size from 2012 to 2022 (in million U.S. dollars)
- Distribution of advanced therapy medicinal products (ATMP) by classification worldwide as of 2016
- Distribution of regenerative medicine companies by world region as of 2019*
- Market capitalization of selected larger gene and cell therapy companies in the U.S. as of 2017 (in billion U.S. dollars)*
- Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phase
- Distribution of advanced therapy medicinal product (ATMP) clinical trials by type of sponsor worldwide as of 2016
- Distribution of non-commercial advanced therapy medicinal product (ATMP) trials by sponsor worldwide as of 2016
- Number of stem-cell and gene therapies in current development as of 2017, by developer
- Percentage of stem-cell and gene therapies in current development as of 2017, by developer
- Global stem cell market size by world region between 2011 and 2016 (in billion U.S. dollars)*
- Distribution of the stem cell technologies and applications market by world region in 2016
- Global stem cell market size in 2016 and a forecast for 2025 (in billion U.S. dollars)*
- Number of hematopoietic stem cell (HSC) transplants in the United States from 2010 to 2015, by source
- Total stem cell research funding by the National Institutes for Health (NIH) from FY 2013 to FY 2018 (in million U.S. dollars)
- Aggregate annual demand of cord blood units (CBUs) in the U.S. from 2010 to 2016*
- Average annual social value of the U.S. cord blood bank system based on donor/patient matching from 2010 to 2016 (in million U.S. dollars)
- Percentage of cord blood units (CBUs) from the U.S. shipped to domestic and international destinations from 2010 to 2016
- Share of U.S. cord blood units (CBUs) shipped by the U.S. by total nucleated cell count (TNC) from 2002 to 2016
- Share of U.S. cord blood units (CBUs) stored by total nucleated cell count (TNC) from 2002 to 2016
- Number of CAR cell therapy trials worldwide from 2007 to 2016*
- Number of CAR cell therapy trials, comparing the U.S. and China from 2009 to 2016*
- Venture capital funding for select companies involved in CAR-T programs between 2011 and 2016 (in million U.S. dollars)*
- Selected IPOs of companies with a CAR-T focus between 2013 and 2015 (in million U.S. dollars)*
- Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure
- Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars)
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*
- Price of select market-stage advanced therapy medicinal products (ATMPs) as of 2016 (in U.S. dollars)
- Do you favor or oppose expanding federal funding for research using embryonic stem cells?
- Average hospital costs for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure (in U.S. dollars)
- Hospital charges and inpatient stay costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicare in 2014, by procedure (in U.S. dollars)
- Average hospital charges for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure (in U.S. dollars)
- Number of hematopoietic stem cell (HSC) transplants in the United States in 2010-2016, by condition and source
- Total number of hematopoietic stem cell (HSC) transplants in the United States in 2010-2016, by condition
- Total number of hematopoietic stem cell (HSC) transplants in the United States from 2010 to 2015
- Percentage of U.S. adults with outpatient hospital treatments within the preceding 5 years as of 2017, by gender
- Level of satisfaction with hospital treatments among U.S. adults as of 2017, by ethnicity
- Percentage of U.S. population who did not receive needed medical care due to cost from 2000 to 2016, by age*
- Level of satisfaction with hospital treatments among U.S. adults as of 2017, by age
- Do you consider medical research using stem cells obtained from human embryos morally acceptable or morally wrong?
- Level of satisfaction with hospital treatments among U.S. adults as of 2017, by gender
- Leading medical conditions U.S. health care workers have been treated for in hospitals as of 2017
- Stem cell assay market value in Latin America in 2018 and 2023 (in million U.S. dollars)
- Leading medical conditions U.S. adults have been treated for in hospitals as of 2017, by community
- Level of satisfaction with public hospital services in Hong Kong as of May 2019
- Revenue of the blood and hematopoietic organs pharmaceuticals market in Argentina from 1st quarter 2017 to 4th quarter 2018 (in million Argentine pesos)
- Number of alcohol-related hospital admissions due to alcoholic liver disease in England in 2013/14, by type
- Number of donations of pancreatic islets and parathyroid tissue in Italy from 2014 to 2017
- Number of hospitals in New Mexico in 2017, by ownership type
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.